about
807 C/T Polymorphism of the glycoprotein Ia gene and pharmacogenetic modulation of platelet response to dual antiplatelet treatmentPlatelet function profiles in patients with type 2 diabetes and coronary artery disease on combined aspirin and clopidogrel treatmentIL-1 cluster genes and occurrence of post-percutaneous transluminal coronary angioplasty restenosis: a prospective, angiography-based evaluationMagnitude and consequences of undertreatment of high-risk patients with non-ST segment elevation acute coronary syndromes: insights from the DESCARTES RegistryContribution of gene sequence variations of the hepatic cytochrome P450 3A4 enzyme to variability in individual responsiveness to clopidogrelInsulin therapy is associated with platelet dysfunction in patients with type 2 diabetes mellitus on dual oral antiplatelet treatmentVariability in individual responsiveness to clopidogrel: clinical implications, management, and future perspectivesImpact of platelet reactivity on cardiovascular outcomes in patients with type 2 diabetes mellitus and coronary artery diseaseA polypill strategy to improve global secondary cardiovascular prevention: from concept to reality.A 30-month worksite-based lifestyle program to promote cardiovascular health in middle-aged bank employees: Design of the TANSNIP-PESA randomized controlled trial.Neutrophil stunning by metoprolol reduces infarct sizePathological effects of pulmonary vein beta-radiation in a swine model.Impact of left ventricular hypertrophy on troponin release during acute myocardial infarction: new insights from a comprehensive translational study.Fractional flow reserve and minimum Pd/Pa ratio during intravenous adenosine infusion: very similar but not always the same.Long term outcome of patients with postinfarction left ventricular pseudoaneurysm.Glycated Hemoglobin, Fasting Insulin and the Metabolic Syndrome in Males. Cross-Sectional Analyses of the Aragon Workers' Health Study Baseline.A Randomized Comparison of Reservoir-Based Polymer-Free Amphilimus-Eluting Stents Versus Everolimus-Eluting Stents With Durable Polymer in Patients With Diabetes Mellitus: The RESERVOIR Clinical Trial.Cost-effectiveness of a European ST-segment elevation myocardial infarction network: results from the Catalan Codi Infart network.Update on ischemic heart disease and intensive cardiac care.Rationale and design of a multicenter, international and collaborative Coronary Artery Aneurysm Registry (CAAR).Impact of Intravenous Lysine Acetylsalicylate Versus Oral Aspirin on Prasugrel-Inhibited Platelets: Results of a Prospective, Randomized, Crossover Study (the ECCLIPSE Trial).Prevalence, Vascular Distribution, and Multiterritorial Extent of Subclinical Atherosclerosis in a Middle-Aged Cohort: The PESA (Progression of Early Subclinical Atherosclerosis) Study.Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIIntramural coronary hematoma, a complex three-dimensional entity: Multimodality assessment.Intravascular ultrasound guidance of percutaneous coronary intervention in ostial chronic total occlusions: a description of the technique and procedural results.Oxidized LDL Is Associated With Metabolic Syndrome Traits Independently of Central Obesity and Insulin Resistance.Association Between a Social-Business Eating Pattern and Early Asymptomatic Atherosclerosis.Long-term benefit of early pre-reperfusion metoprolol administration in patients with acute myocardial infarction: results from the METOCARD-CNIC trial (Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction).Incidence, Causes, and Impact of In-Hospital Infections After Transcatheter Aortic Valve Implantation.Accurate quantification of atherosclerotic plaque volume by 3D vascular ultrasound using the volumetric linear array method.Cause and Long-Term Outcome of Cardiac Tamponade.Results of the first clinical study of adjunctive CAldaret (MCC-135) in patients undergoing primary percutaneous coronary intervention for ST-Elevation Myocardial Infarction: the randomized multicentre CASTEMI study.Incidence, Causes, and Predictors of Early (≤30 Days) and Late Unplanned Hospital Readmissions After Transcatheter Aortic Valve Replacement.Efficacy and safety of left atrial appendage closure versus medical treatment in atrial fibrillation: a network meta-analysis from randomised trials.Role of thrombosis in atherosclerosis and its complications.Early Intravenous Beta-Blockers in Patients With ST-Segment Elevation Myocardial Infarction Before Primary Percutaneous Coronary Intervention.Femoral and Carotid Subclinical Atherosclerosis Association With Risk Factors and Coronary Calcium: The AWHS Study.Incidence, Management, and Immediate- and Long-Term Outcomes After Iatrogenic Aortic Dissection During Diagnostic or Interventional Coronary Procedures.Lower-normal TSH is associated with better metabolic risk factors: A cross-sectional study on Spanish men.Usefulness of echocardiographic criteria for transcatheter aortic valve implantation without balloon predilation: a single-center experience.
P50
Q28169034-0393D8C6-EB79-4E68-8309-29552919D8C2Q28185431-7C7FC4E2-5181-41A8-9E84-D13EF3EDAB07Q28188005-FDFFDA91-09DC-4677-9E00-97C393F7BB8AQ28196868-C2859DFE-3E52-4B3C-8A57-C76D05F11FADQ28196881-40D9A60E-9F32-44C9-BF45-5283BFCE1795Q28199546-4D3966DA-491B-4AE8-AE4B-0B4405E314C5Q28222158-BFA17E7D-9749-432E-A751-E7A01055CE1CQ28222643-8AE2298A-29CB-4243-B60B-D39E34B30356Q30365510-1DEBAD25-41FC-48C1-87A6-2314806D4A48Q33459018-A344404F-5FD5-412F-8BE8-B344D421775BQ33587119-DE495A0B-C633-455F-BE33-A6107755F1C2Q33845001-E9449FD4-896B-43D3-BB4A-D1323C055DE2Q35088064-8CBADF99-9255-4E37-A6A8-4E28F84A1849Q35389236-395B3DBE-D252-4F8A-B990-9824C37C8C24Q35581699-A6CBA759-F4FD-4F40-B206-0A306B1E411BQ35737628-68473EBB-9D86-4D64-B53A-890DDC306930Q35893235-E084FF38-7D9A-48AF-A987-C6F89D193549Q36374003-EB239643-286E-4004-B3B9-DD880FAEF407Q38351394-B52DFFA2-B94D-4C76-8B30-12756534CCAEQ38379047-DC83B703-F075-4969-966E-CBA38FBCA24BQ38411860-0D64C82F-A7FD-47AA-B870-353A0468AFBBQ38413126-E546CBE2-77EF-4250-9247-485B843323DDQ38445186-B3A28E05-0B1A-4FFF-9CC3-BB7D26AF1F12Q38876682-09866154-E649-472B-AE0E-C2949E9E08FDQ38961151-A7852213-5F9C-468F-8798-F02849F3F689Q39086114-0591E238-47BE-4800-AC27-AD65AEB3B4D0Q39352900-BAD90F24-55C1-4A71-BA0E-31A0CF61A088Q39359162-F05D84B6-40A2-4685-A436-F49EDB82037CQ39687005-D5B239BC-87EC-449E-B5E4-267F469E0941Q39869432-42475450-0DF1-4F00-AE94-CA840A77A083Q40124762-6FB6F50F-045B-487B-912C-18356064D0ADQ40280772-1950AE66-82EA-4C78-8B5C-B532A34BC4A0Q40420608-269FBB38-09F9-4D35-B33C-205B8BD8606CQ40597502-F8A27419-6A9F-4CC6-8D55-54300C50144EQ40597995-40AB7BF7-D7C1-46A7-BEA2-F5D6634D2AE8Q40815387-27548C0D-025B-4ADC-91E1-1E6F47737F71Q40846843-67FF9555-8660-4E97-A109-ED4E5ED8D7E4Q41048601-59316379-89BD-4975-8E73-95477FD40856Q41137223-6460B376-C5EE-4A49-844D-44F68777F750Q41452226-A49DE6ED-1D9A-4331-8E8A-00A435A1E1F2
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Antonio Fernandez-Ortiz
@ast
Antonio Fernandez-Ortiz
@en
Antonio Fernandez-Ortiz
@es
Antonio Fernandez-Ortiz
@nl
Antonio Fernandez-Ortiz
@sl
type
label
Antonio Fernandez-Ortiz
@ast
Antonio Fernandez-Ortiz
@en
Antonio Fernandez-Ortiz
@es
Antonio Fernandez-Ortiz
@nl
Antonio Fernandez-Ortiz
@sl
prefLabel
Antonio Fernandez-Ortiz
@ast
Antonio Fernandez-Ortiz
@en
Antonio Fernandez-Ortiz
@es
Antonio Fernandez-Ortiz
@nl
Antonio Fernandez-Ortiz
@sl
P1053
B-2227-2017
P106
P21
P31
P3829
P496
0000-0002-3239-1910